Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-01-23

FDA Approved: BUMETANIDE — Original Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

FDA approved Bumetanide under an Original Application for Upsher-Smith Laboratories, establishing a generic version of the loop diuretic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUMETANIDE (bumetanide)

Snippet

ORIG AP for BUMETANIDE (BUMETANIDE)